FWM
VBIV

Frontier Wealth Management’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Frontier Wealth Management’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$487K Hold
20,060
– – 0.04% 243
2022
Q1 		$951K Buy
20,060
+18,860
+1,572% +$932K 0.01% 185
2021
Q4 		$84K Hold
1,200
– – 0.01% 416
2021
Q3 		$112K Sell
1,200
-20,000
-94% -$1.9M 0.01% 409
2021
Q2 		$2.13M Hold
21,200
– – 0.15% 115
2021
Q1 		$1.98M Hold
21,200
– – 0.15% 108
2020
Q4 		$1.75M Buy
21,200
+1,200
+6% +$102K 0.14% 111
2020
Q3 		$1.72M Hold
20,000
– – 0.16% 105
2020
Q2 		$1.86M Buy
+20,000
New +$1.1M 0.17% 101

Other funds holding VBIV

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
GAI
General American Investors New York $1.51B AUM 37.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return